Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Industry May Like FDA's Biosimilar Guidance Withdrawal, But Not The New Information Vacuum

Jun 22 2018

• By Derrick Gingery

Guidance word in red keyboard buttons

Related Content

US FDA Biosimilar Guidance Update Will Relax Interchangeability Standards

Apr 21 2018

Biosimilars Statistical Guidance Reflects Early Development Approach

Sep 22 2017

Biosimilar Sponsors Seek Statistical Flexibility When Reference Products Change

Dec 21 2017

Biosimilars: Postmarketing Data Alone Not Enough For Interchangeability

Jan 18 2017

US FDA's Biosimilars Program: Five Years In, Complete Response Letters Still Outnumber Approvals

May 29 2018

Additional Topics

United States Biosimilars FDA Regulation BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window